US equities |
NVDA $238.90 ▲+2.12% SPCX $171.09 ▲+7.63% MU $1,063.96 ▼-1.02% TSLA $378.73 ▲+2.20% WBD $30.95 ▲+0.03% MSFT $525.18 ▲+1.48% AAPL $332.89 ▼-0.24% META $741.90 ▲+1.90%
FinancialContent

Articles published by EVERZOM

News headline image
EVerZom successfully completes CTA-enabling preclinical studies of EVerGel™ required to support a clinical trial application
From EVERZOM
Via GlobeNewswire
News headline image
EVerZom raises €10M to develop exosome-based biotherapies for inflammatory diseases
From EVERZOM
Via GlobeNewswire
News headline image
EVerZom achieves first bioproduction of clinical grade stem cell-derived exosomes in large scale bioreactors in partnership with the French Blood Establishment (EFS) with unprecedented yields
From EVERZOM
Via GlobeNewswire
News headline image
Exclusive license agreement secured with Erganeo for EVerGel, EVerZom's first drug candidate, a breakthrough treatment for fistulas and fibrosis of the digestive tract.
From Everzom
Via GlobeNewswire
News headline image
EVerZom: Therapeutic Ambition in Exosome Biotherapies
From Everzom
Via GlobeNewswire
News headline image
Signing of Exclusive Distributorship Agreement With EVERZOM
From EVerZom
Via Business Wire
News headline image
OmniSpirant and EVerZom Team up to Develop a New Gene Therapy Treatment for Lung Cancer With Extracellular Vesicles
From EVerZom
Via Business Wire
News headline image
Winner of the European EIC Accelerator Program, EVerZom Accelerates the Industrialization of Its Exosome Bioproduction Platform for Regenerative Medicine
From EVerZom
Via Business Wire